Skip to main content
A women caring for several children

“Counting Care In” with Riane Eisler and Gus Speth [Webinar]

Gus Speth

Gus Speth

Co-chair of The Next System Project more

Riane Eisler

Riane Eisler

Author, consultant, and President of the Center for Partnership Studies more

Health & Wellbeing Gender & Sexuality

Measuring the real value of care is the cornerstone of the systemic changes needed to address the unfolding crises in our economic, political, and social world. Find out why on April 14, as The Caring Economy Campaign’s Riane Eisler and The Next System Project’s Gus Speth join together to present the free webinar “Counting Care In.”

Thursday, April 14, 2016
11am Pacific Time
REGISTER HERE

Join us in April and learn:

  • How Social Wealth Economic Indicators (SWEIs) can help build a strong economy that values and invests in the essential work of care
  • How SWEIs provide the evidence-base you need to make the case for caring policies such as paid parental and sick leave, caregiver tax credits, better pay for care workers and educators, and increased investment in early childhood care and education
  • How the SWEIs raise awareness around gender and care that make it essential to explicitly make those foundational dynamics visible.
Gus Speth

Gus Speth

Co-chair of The Next System Project more

Riane Eisler

Riane Eisler

Author, consultant, and President of the Center for Partnership Studies more

More related work

Doctor at work

Primary health care is in critical condition. Making primary care public will restore its health—and protect ours

To avoid the catastrophic effects on our health and our economy of hollowing out our primary care system, the U.S. should create a national program for universal public primary care. read more
Public pharmaceutical

Public pharmaceuticals

Public pharmaceutical enterprises are free from the constraints of profit maximization and can define their bottom line based on such values as their contributions to public health and local economic resiliency. read more
Biomed Europa

Biomed Europa: A challenge to the pharmaceutical oligopoly

In his new white paper, “Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly,” Italian economist Massimo Florio proposes an international, transparent, public phar read more